Global law firm Freshfields advised Charterhouse Capital Partners (“Charterhouse”), one of the longest established private equity firms operating in Europe, on its strategic investment in Winback, a leading French medtech company specialising in non-invasive medical, rehabilitation, sports recovery, and aesthetic technologies, in partnership with Winback’s management team, who will reinvest significantly in the business. CAPZA, the existing minority shareholder, which has backed the group since 2021, will exit as part of the transaction.

Founded in 2013, Winback is a global leader specialising in TECAR and radiofrequency therapy, cryotherapy and compression systems and digital service solutions used across physiotherapy, sports medicine, chronic pain, women’s health, and aesthetic care. Headquartered in Biarritz, France, the platform has a fully integrated value chain including proprietary technology that services over 15,000 clinics and practices across 55 countries, with circa 60% of its sales generated internationally.

The Freshfields team was led by partner Yann Gozal, with senior associate Aia Eid on the corporate aspects. Partner Marie Roche and counsel Thomas Jeannin advised on finance aspects.